TY  - GEN
AU  - Shibata,Stephen I
AU  - Doroshow,James H
AU  - Frankel,Paul
AU  - Synold,Timothy W
AU  - Yen,Yun
AU  - Gandara,David R
AU  - Lenz,Heinz-Josef
AU  - Chow,Warren A
AU  - Leong,Lucille A
AU  - Lim,Dean
AU  - Margolin,Kim A
AU  - Morgan,Robert J
AU  - Somlo,George
AU  - Newman,Edward M
TI  - Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study
SN  - 1432-0843
PY  - 2009///0917
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Capecitabine
KW  - Deoxycytidine
KW  - Drug Therapy, Combination
KW  - Female
KW  - Fluorouracil
KW  - Gene Expression
KW  - drug effects
KW  - Humans
KW  - Leukocytes, Mononuclear
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - drug therapy
KW  - Neoplasms
KW  - Oligodeoxyribonucleotides
KW  - Organoplatinum Compounds
KW  - Oxaliplatin
KW  - Ribonucleoside Diphosphate Reductase
KW  - antagonists & inhibitors
KW  - Treatment Outcome
KW  - Tumor Suppressor Proteins
KW  - genetics
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1007/s00280-009-0977-x
ER  -